Calcineurin A versus NS5A-TP2/HD Domain Containing 2: A Case Study of Site-directed Low-frequency Random Mutagenesis for Dissecting Target Specificity of Peptide Aptamers

We previously identified a peptide aptamer (named R5G42) via functional selection for its capacity to slow cell proliferation. A yeast two-hybrid screen of human cDNA libraries, using R5G42 as “bait,” allowed the identification of two binding proteins with very different functions: calcineurin A (CnA) (PP2B/PPP3CA), a protein phosphatase well characterized for its role in the immune response, and NS5A-TP2/HD domain containing 2, a much less studied protein induced subsequent to hepatitis C virus non-structural protein 5A expression in HepG2 hepatocellular carcinoma cells, with no known activity. Our objective in the present study was to dissect the dual target specificity of R5G42 in order to have tools with which to better characterize the actions of the peptide aptamers toward their individual targets. This was achieved through the selection of random mutants of the variable loop, derived from R5G42, evaluating their specificity toward CnA and NS5A-TP2 and analyzing their sequence. An interdisciplinary approach involving biomolecular computer simulations with integration of the sequence data and yeast two-hybrid binding phenotypes of these mutants yielded two structurally distinct conformers affording the potential molecular basis of the binding diversity of R5G42. Evaluation of the biological impact of CnA- versus NS5A-TP2-specific peptide aptamers indicated that although both contributed to the anti-proliferative effect of R5G42, CnA-binding was essential to stimulate the nuclear translocation of nuclear factor of activated T cells, indicative of the activation of endogenous CnA. By dissecting the target specificity of R5G42, we have generated novel tools with which to study each target individually. Apta-C8 is capable of directly activating CnA independent of binding to NS5A-TP2 and will be an important tool in studying the role of CnA activation in the regulation of different signaling pathways, whereas Apta-E1 will allow dissection of the function of NS5A-TP2, serving as an example of the usefulness of peptide aptamer technology for investigating signaling pathways.

[1]  G. Hummer,et al.  The Molecular Mechanism of Substrate Engagement and Immunosuppressant Inhibition of Calcineurin , 2013, PLoS biology.

[2]  A. Rust,et al.  Insertional mutagenesis identifies multiple networks of co-operating genes driving intestinal tumorigenesis , 2011, Nature Genetics.

[3]  Christian V. Forst,et al.  Image-Based Genome-Wide siRNA Screen Identifies Selective Autophagy Factors , 2011, Nature.

[4]  G. Uhl,et al.  Genomic Regions Identified by Overlapping Clusters of Nominally-Positive SNPs from Genome-Wide Studies of Alcohol and Illegal Substance Dependence , 2011, PloS one.

[5]  C. Garrido,et al.  Targeting cancer with peptide aptamers , 2011, Oncotarget.

[6]  Francesca Fanelli,et al.  Wordom: A User-Friendly Program for the Analysis of Molecular Structures, Trajectories, and Free Energy Surfaces , 2010, J. Comput. Chem..

[7]  Keith A. Boroevich,et al.  Comparative Genomics Identifies Candidate Genes for Infectious Salmon Anemia (ISA) Resistance in Atlantic Salmon (Salmo salar) , 2010, Marine Biotechnology.

[8]  K. Sakuma,et al.  The Functional Role of Calcineurin in Hypertrophy, Regeneration, and Disorders of Skeletal Muscle , 2010, Journal of biomedicine & biotechnology.

[9]  R. Nussinov,et al.  The role of dynamic conformational ensembles in biomolecular recognition. , 2009, Nature chemical biology.

[10]  Jianpeng Ma,et al.  CHARMM: The biomolecular simulation program , 2009, J. Comput. Chem..

[11]  L. Tong,et al.  Distinct gene subsets in pterygia formation and recurrence: dissecting complex biological phenomenon using genome wide expression data , 2009, BMC Medical Genomics.

[12]  L. Hood,et al.  Systems medicine: the future of medical genomics and healthcare , 2009, Genome Medicine.

[13]  R. Finnell,et al.  Large-scale gene trapping in C57BL/6N mouse embryonic stem cells. , 2008, Genome research.

[14]  P. Carloni,et al.  Peptide aptamers targeting mutant p53 induce apoptosis in tumor cells. , 2008, Cancer research.

[15]  Tuan Nguyen,et al.  NFAT signaling in neural development and axon growth , 2008, International Journal of Developmental Neuroscience.

[16]  E. Olson,et al.  Stimulation of calcineurin Aalpha activity attenuates muscle pathophysiology in mdx dystrophic mice. , 2008, American journal of physiology. Regulatory, integrative and comparative physiology.

[17]  Geerten W Vuister,et al.  An allosteric intramolecular PDZ-PDZ interaction modulates PTP-BL PDZ2 binding specificity. , 2007, Biochemistry.

[18]  B. de Chassey,et al.  An Antiproliferative Genetic Screening Identifies a Peptide Aptamer That Targets Calcineurin and Up-regulates Its Activity* , 2007, Molecular & Cellular Proteomics.

[19]  M. Bickle,et al.  Selection and characterization of large collections of peptide aptamers through optimized yeast two-hybrid procedures , 2006, Nature Protocols.

[20]  E. Olson,et al.  Activated calcineurin ameliorates contraction‐induced injury to skeletal muscles of mdx dystrophic mice , 2006, The Journal of physiology.

[21]  David J. Earl,et al.  Parallel tempering: theory, applications, and new perspectives. , 2005, Physical chemistry chemical physics : PCCP.

[22]  J. Molkentin,et al.  Calcium-calcineurin signaling in the regulation of cardiac hypertrophy. , 2004, Biochemical and biophysical research communications.

[23]  A. Chiò,et al.  Activity of protein phosphatase calcineurin is decreased in sporadic and familial amyotrophic lateral sclerosispatients , 2004, Journal of neurochemistry.

[24]  F. Hoppe-Seyler,et al.  Peptide aptamers: specific inhibitors of protein function. , 2004, Current molecular medicine.

[25]  Nathan A. Baker,et al.  PDB2PQR: an automated pipeline for the setup of Poisson-Boltzmann electrostatics calculations , 2004, Nucleic Acids Res..

[26]  Jun Cheng,et al.  Cloning and identification of NS5ATP2 gene and its spliced variant transactivated by hepatitis C virus non-structural protein 5A. , 2004, World journal of gastroenterology.

[27]  N. Stupka,et al.  The calcineurin signal transduction pathway is essential for successful muscle regeneration in mdx dystrophic mice , 2004, Acta Neuropathologica.

[28]  H. Ke,et al.  Structures of calcineurin and its complexes with immunophilins-immunosuppressants. , 2003, Biochemical and biophysical research communications.

[29]  Bernd Groner,et al.  Sequence-specific Peptide Aptamers, Interacting with the Intracellular Domain of the Epidermal Growth Factor Receptor, Interfere with Stat3 Activation and Inhibit the Growth of Tumor Cells* , 2003, Journal of Biological Chemistry.

[30]  B. Groner,et al.  Bifunctional recombinant proteins in cancer therapy: cell penetrating peptide aptamers as inhibitors of growth factor signaling , 2003, Journal of Cancer Research and Clinical Oncology.

[31]  Hwa-Young Kim,et al.  Crystal structure of calcineurin–cyclophilin–cyclosporin shows common but distinct recognition of immunophilin–drug complexes , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[32]  A. Simard,et al.  Calcineurin and skeletal muscle growth , 2002, Nature Cell Biology.

[33]  T. Morgan,et al.  Chronic Overexpression of the Calcineurin Inhibitory Gene DSCR1 (Adapt78) Is Associated with Alzheimer's Disease* , 2001, The Journal of Biological Chemistry.

[34]  C. Klee,et al.  Low affinity Ca2+-binding sites of calcineurin B mediate conformational changes in calcineurin A. , 2000, Biochemistry.

[35]  E. Olson,et al.  Remodeling muscles with calcineurin , 2000, BioEssays : news and reviews in molecular, cellular and developmental biology.

[36]  M. Kubo,et al.  Synergism between the Calmodulin-binding and Autoinhibitory Domains on Calcineurin Is Essential for the Induction of Their Phosphatase Activity* , 2000, The Journal of Biological Chemistry.

[37]  M. Karplus,et al.  Effective energy function for proteins in solution , 1999, Proteins.

[38]  E V Koonin,et al.  The HD domain defines a new superfamily of metal-dependent phosphohydrolases. , 1998, Trends in biochemical sciences.

[39]  W. Zhu,et al.  A calcineurin-dependent transcriptional pathway controls skeletal muscle fiber type. , 1998, Genes & development.

[40]  Hao Ren,et al.  Regulation of the Calmodulin-stimulated Protein Phosphatase, Calcineurin* , 1998, The Journal of Biological Chemistry.

[41]  R. Brent,et al.  Cells that register logical relationships among proteins. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[42]  Roger Brent,et al.  Genetic selection of peptide aptamers that recognize and inhibit cyclin-dependent kinase 2 , 1996, Nature.

[43]  K Schulten,et al.  VMD: visual molecular dynamics. , 1996, Journal of molecular graphics.

[44]  R. Brent,et al.  Correlation of two-hybrid affinity data with in vitro measurements , 1995, Molecular and cellular biology.

[45]  D. Koshland.  The Key–Lock Theory and the Induced Fit Theory , 1995 .

[46]  I. Grundke‐Iqbal,et al.  Dephosphorylation of Alzheimer's disease abnormally phosphorylated tau by protein phosphatase-2A , 1994, Neuroscience.

[47]  Roger Brent,et al.  C dil, a Human Gl and S Phase Protein Phosphatase That Associates with Cdk2 , 2003 .

[48]  G. F. Joyce,et al.  Randomization of genes by PCR mutagenesis. , 1992, PCR methods and applications.

[49]  A. Gronenborn,et al.  High-resolution three-dimensional structure of reduced recombinant human thioredoxin in solution. , 1992, Biochemistry.

[50]  K. Takano.  ON SOLUTION OF , 1983 .

[51]  C. Klee,et al.  Calcineurin: a calcium- and calmodulin-binding protein of the nervous system. , 1979, Proceedings of the National Academy of Sciences of the United States of America.

[52]  G. Ciccotti,et al.  Numerical Integration of the Cartesian Equations of Motion of a System with Constraints: Molecular Dynamics of n-Alkanes , 1977 .

[53]  J. Changeux,et al.  ON THE NATURE OF ALLOSTERIC TRANSITIONS: A PLAUSIBLE MODEL. , 1965, Journal of molecular biology.

[54]  M. Bickle,et al.  Peptide aptamers for small molecule drug discovery. , 2009, Methods in molecular biology.

[55]  K. Oldenburg,et al.  Recombination-mediated PCR-directed plasmid construction in vivo in yeast. , 1997, Nucleic acids research.

[56]  D. Botstein,et al.  Plasmid construction by homologous recombination in yeast. , 1987, Gene.